Nucleus Software Exports Ltd (NUCLEUS)

Information Technology · IT - Software · NSE · Updated 2 September 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹740.05 ↓ 27.99% (1Y)

🎯 Key Takeaways

  • Nucleus Software Exports is navigating a transitional phase marked by declining profitability and revenue trends, yet management remains committed to strategic reinvestment in AI, product innovation, and global expansion despite short-term financial headwinds. The company maintains a strong balance sheet with no debt and consistent dividend payouts, reflecting a capital allocation discipline focused on shareholder returns amid operational volatility.
  • Revenue declined 6.4% QoQ to ₹210 in Q1FY27.
  • ⚠️ Sustained revenue and profit decline across four consecutive quarters without a clear inflection point.
Market Cap
₹1,948
P/E Ratio
18.5
P/B Ratio
2.15
ROE
11.6%
ROCE
14.7%
Debt/Equity
0.00
Div Yield
1.69%
Promoter
73.6%

📖 The Story

Nucleus Software Exports is navigating a transitional phase marked by declining profitability and revenue trends, yet management remains committed to strategic reinvestment in AI, product innovation, and global expansion despite short-term financial headwinds. The company maintains a strong balance sheet with no debt and consistent dividend payouts, reflecting a capital allocation discipline focused on shareholder returns amid operational volatility.

📰 What's Happening

In Q1 FY26 (ended June 2026), consolidated revenue declined 3.8% YoY to ₹210.43 crores, with PAT falling 32% to ₹23.87 crores, driven by margin compression and lower operational efficiency. Management attributed the dip to macroeconomic pressures but emphasized continued investment in AI, product innovation, and global market development. The Board approved a final dividend of ₹12.50 per share and granted 250,000 RSUs, while also reducing liability provisions to improve net worth. Shareholders reaffirmed confidence at the 37th AGM by approving financial statements and reappointing key leadership, including MD Vishnu R Dusad and Director Parag Bhise.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricSep 2025Dec 2025Mar 2026Jun 2026
Revenue214220225210
Operating Profit2029303
OPM %9.2%13.1%13.4%1.3%
Net Profit26213524
EPS₹9.99₹7.86₹13.12₹9.07

The sequential revenue trend shows a clear downward trajectory: ₹225 crores (Mar 2026) → ₹220 crores (Dec 2025) → ₹214 crores (Sep 2025) → ₹210 crores (Jun 2026), indicating weakening demand or execution challenges. While operating margins improved slightly in the latest quarter to 1.3% from 9.2% previously, this came amid lower revenue and reduced profitability. Net profit declined sharply from ₹35 crores to ₹24 crores, reflecting both top-line pressure and higher cost structures. Management attributes this to temporary factors but has not provided a clear path to margin recovery, raising concerns about near-term earnings sustainability.

🔮 Management Outlook & What's Next

Management has reiterated its focus on long-term growth through product innovation, AI integration, and expansion of the global partner network, signaling a strategic patience approach to profitability. No specific revenue or margin targets were provided in the latest commentary, but capital allocation appears aligned with sustaining R&D and international footprint development. The absence of near-term guidance suggests confidence in gradual improvement, though execution risks remain elevated given the consistent quarterly declines.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

ItemMar 2025Mar 2025Mar 2026Mar 2026
Equity Capital26262626
Reserves690788822881
Borrowings3280
Total Liabilities1,1471,1531,2301,266
Fixed Assets56607477
Investments656641676656
Total Assets1,1471,1531,2301,266

The balance sheet remains exceptionally conservative, with zero net debt and equity of ₹26 crores supported by substantial reserves of ₹881 crores as of March 2026. This financial resilience enables ongoing investments and dividend payouts without leverage risk. However, the modest growth in reserves and equity suggests limited reinvestment or retained earnings growth, likely due to profit declines. The company is prioritizing capital efficiency and balance sheet strength over aggressive expansion, consistent with its disciplined financial approach.

💰 Cash Flow Statement (₹ Cr)

ItemMar 2026
Operating+117
Investing-53
Financing-37
Net Cash Flow+28

👥 Shareholding Pattern

CategoryQ2FY26Q3FY26Q4FY26Q1FY27
Promoters73.6%73.6%73.6%73.6%
FII5.2%4.9%4.5%3.3%
DII1.5%1.4%1.2%1.5%
Public16.9%17.0%17.6%18.3%
# Shareholders42,19241,15739,64840,028

Institutional investor interest appears to be gradually declining, with FII holdings reducing from 5.18% in Q2FY26 to 3.32% in Q1FY27, while DII holdings have remained relatively stable. Promoter holding remains steady at 73.6%, indicating no stake sale by management. The gradual exit of foreign investors may reflect concerns over growth visibility or sectoral rotation, though the consistent retail investor base and high number of shareholders suggest stability in ownership structure. No pledging activity is evident.

⚖️ Peer Comparison — IT - Software

Company MCap (₹ Cr) P/E ROCE ROE D/E
TCS 8.56 L Cr 17.2 63.2% 46.7% 0.00
INFY 4.68 L Cr 15.6 44.9% 32.7% 0.00
HCLTECH 3.67 L Cr 21.0 31.6% 23.2% 0.00
WIPRO 1.80 L Cr 14.4 18.1% 15.1% 0.19
TECHM 1.60 L Cr 28.2 24.8% 17.4% 0.00
LTM 1.37 L Cr 26.1 30.5% 21.6% 0.00
OFSS 1.06 L Cr 30.9 60.3% 43.6% 0.00
PERSISTENT 91,416 47.0 32.7% 24.5% 0.00
COFORGE 87,786 40.3 25.6% 20.7% 0.04
MPHASIS 47,828 25.0 22.3% 17.8% 0.17

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Sustained revenue and profit decline across four consecutive quarters without a clear inflection point. 2. Margin compression despite cost control efforts, with OPM falling to 1.3% in Q1FY27 from over 13% in prior quarters. 3. Lack of near-term visibility on growth catalysts, with management guidance remaining vague. 4. Potential dilution from RSU grants and dividend sustainability amid shrinking profits. These factors collectively pose execution and earnings volatility risks.

📋 Recent Filings

🧠 Analyst's Read

Nucleus Software is undergoing a strategic phase where long-term investments are being funded amid short-term financial pressure. While the balance sheet provides resilience and shareholder returns continue, the lack of earnings recovery and declining top-line trends warrant close monitoring. Investors should watch for sequential improvement in revenue and margins in upcoming quarters to confirm the sustainability of the company's growth strategy.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NUCLEUS files new disclosures

Track NUCLEUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NUCLEUS — Free

Free account · 2 AI queries/day